AnaptysBio, Inc. (ANAB) Tops Q4 EPS by 90c
Tweet
Share
E-mail
Get Alerts ANAB Hot Sheet
Join SI Premium – FREE
AnaptysBio, Inc. (NASDAQ: ANAB) reported Q4 EPS of ($0.72), $0.90 better than the analyst estimate of ($1.62). Revenue for the quarter came in at $43.11 million versus the consensus estimate of $8.44 million.
For earnings history and earnings-related data on AnaptysBio, Inc. (ANAB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Upgrades Cintas (CTAS) to Buy
- BofA Securities Downgrades W.R. Berkley (WRB) to Underperform
- Evercore ISI Adds Arista Networks (ANET) to TAP Outperform List
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
